Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2314-8543
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy ; volume:11 ; number:1 ; day:11 ; month:4 ; year:2022 ; pages:1-14 ; date:12.2022
Beni-Suef University Journal of Basic and Applied Sciences / Ǧāmiʿat Banī-Suwaif ; 11, Heft 1 (11.4.2022), 1-14, 12.2022
- Urheber
-
Hussain, Amina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43088-022-00238-8
- URN
-
urn:nbn:de:101:1-2022062621231198563729
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hussain, Amina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Generation of macrophages with enhanced functionality using chimeric antigen receptors
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric antigen receptors: unleashing a new age of anti-cancer therapy
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Modular modification of chimeric antigen receptors sheds light on T cell activation
A novel luciferase-based assay for the detection of Chimeric Antigen Receptors
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Generation of macrophages with enhanced functionality using chimeric antigen receptors
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric antigen receptors: unleashing a new age of anti-cancer therapy
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Modular modification of chimeric antigen receptors sheds light on T cell activation
A novel luciferase-based assay for the detection of Chimeric Antigen Receptors
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Generation of macrophages with enhanced functionality using chimeric antigen receptors
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric antigen receptors: unleashing a new age of anti-cancer therapy
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Modular modification of chimeric antigen receptors sheds light on T cell activation
A novel luciferase-based assay for the detection of Chimeric Antigen Receptors
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies